http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103275944-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-1029 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C11B3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A21D8-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-10 |
filingDate | 2004-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103275944-B |
titleOfInvention | Protein |
abstract | The present invention relates to the method for generating glycolipid acyltransferase variant; including: (a) selects to be characterized as that the glycolipid acyltransferase comprising aa sequence motifs GDSX is as parent enzyme, one or more during wherein X is following amino acid residue: L, A, V, I, F, Y, H, Q, T, N, M, S;B () modifies one or more aminoacid to generate glycolipid acyltransferase variant;C () tests transferase active and the optionally hydrolyse activity of glycolipid acyltransferase variant on galactolipid substrate and optional phospholipid substrate and/or optional triglyceride substrate;D () selects the enzyme variants that the specific activity parent enzyme to galactolipid raises;And optionally (e) prepares a certain amount of enzyme variants.The invention still further relates to be characterized as comprising the acyltransferase variant of aa sequence motifs GDSX; one or more during wherein X is following amino acid residue: L, A, V, I, F, Y, H, Q, T, N, M or S, and wherein enzyme variants comprises one or more amino acid modified relative to parental array at one or more amino acid residues that the 2nd group, the 4th group, the 6th group or the 7th group limit. |
priorityDate | 2003-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 440.